Skip to main content

Table 2 Gene expression fold change in the LNCaP model treated with Casodex.

From: Casodex treatment induces hypoxia-related gene expression in the LNCaP prostate cancer progression model

  

Fold Change

GenBank#

Name

LNCaP-R Control vs. Treated

LNCaP-UR Control vs. Treated

T73556

fatty-acid-Coenzyme A ligase

- 2.09

- 3.68

R98851

membrane metallo-endopeptidase

+ 5.44

+ 1.94

AA063521

BCL2/adenovirus E1B 19 kD

+ 3.66

+ 1.84

AA459039

serine protease inhibitor, Kunitz type,

+ 3.61

+ 1.58

AA489752

cyclin G2

+ 3.84

+ 2.19

  1. (+, fold up regulated and -, fold downregulated)